MK-677 for muscle growth: separating gym lore from clinical data

What did @nxtlevelsupplements actually say?

The creator positioned MK-677 as a growth hormone secretagogue that stimulates IGF-1 production, boosts ghrelin to drive appetite, and helps people eat enough to gain mass. They correctly separated it from SARMs, noting it does not bind to androgen receptors. They also called it "a research chemical, not a dietary supplement," which is the most honest line in the whole video. The pitch ends with a promo code for their own product, which is worth keeping in mind when evaluating the framing.

The core claims were: MK-677 raises IGF-1, increases ghrelin, improves sleep, hair, nails, and skin, does not cause overnight size gains, and differs mechanistically from SARMs. Some of those claims have more support than others.

Does the science back this up?

Partially. The mechanism is real, but the benefit list gets stretched further than the evidence allows. MK-677 is an orally active ghrelin mimetic that stimulates growth hormone secretion from the pituitary, which in turn raises IGF-1. That part is well-documented. The appetite effect from ghrelin agonism is also real and measurable.

A randomized controlled trial by Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism) confirmed that MK-677 increases GH and IGF-1 in elderly subjects and improves nitrogen balance, suggesting anabolic effects on lean mass over time. Sleep architecture improvements, specifically increased REM and stage IV sleep, were reported in a small trial by Copinschi et al. (1997, Sleep). The hair, nail, and skin quality claims, however, are not directly supported by clinical trial data. Those appear to be logical extrapolations from IGF-1's known role in tissue maintenance, not outcomes that have been studied in MK-677 trials.

What did they get wrong (or right)?

Credit where it is due: calling MK-677 a research chemical rather than a supplement is accurate and more responsible than most influencer content in this space. The SARM distinction is also correct. MK-677 is not a selective androgen receptor modulator. It does not bind to androgen receptors. The creator explained that clearly.

What they got wrong is the IGF-1 framing. They said MK-677 "makes your body produce more IGF-1, which is a growth hormone." IGF-1 is not growth hormone. IGF-1 is insulin-like growth factor 1, a downstream mediator released primarily by the liver in response to growth hormone stimulation. Conflating the two is a basic endocrinology error. Growth hormone triggers IGF-1 release; they are not the same molecule.

The hair, nail, and skin quality claims also go beyond what controlled data supports. These are popular talking points in the bodybuilding community but they lack clinical trial backing specific to MK-677 use.

What should you actually know?

MK-677 is not approved by the FDA as a drug or recognized as a legal dietary supplement. The FDA has issued warning letters related to SARMs and associated compounds sold as supplements, and MK-677 sits in a similarly gray regulatory space. Buying it from a supplement retailer does not make it a supplement under the law.

The side effect profile matters here and the video skips it entirely. Chronically elevated GH and IGF-1 carry real risks. A two-year trial by Nass et al. (2008, Annals of Internal Medicine) found that MK-677 increased fasting blood glucose and insulin resistance in older adults. Water retention, increased appetite beyond what is useful, and potential impacts on insulin sensitivity are documented concerns, not hypotheticals. Anyone considering this compound should have those conversations with a licensed clinician, not a supplement retailer with a promo code.

The conflict of interest is the headline

The creator opens with "if you're going to take this information from anybody, take it from me" and closes by selling you the product. That is a significant conflict of interest. The mechanistic information they shared is mostly accurate, but the omission of side effects and regulatory status, combined with a direct sales pitch, makes this educational content that serves a commercial goal first. Weight that accordingly.